Lactoferricin Blocks Dangerous Bacteria From Sticking to and Invading Human Cells

Bovine lactoferricin reduced adhesion and invasion of enteropathogenic Yersinia to human cells in a dose-dependent manner — preventing bacterial cell entry, not just killing bacteria.

Di Biase, Assunta Maria et al.·Journal of medical microbiology·2004·Preliminary Evidencein-vitro
RPEP-00902In VitroPreliminary Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Bovine lactoferricin dose-dependently reduced Yersinia adhesion to and invasion of HEp-2 cells even at sub-bactericidal concentrations, demonstrating anti-virulence activity complementing its bactericidal effects.

Key Numbers

How They Did This

In-vitro infection study. Bovine lactoferricin at various concentrations incubated with enteropathogenic Yersinia and HEp-2 cells. Adhesion and invasion quantified by gentamicin protection assay.

Why This Research Matters

Preventing bacteria from invading cells is potentially more effective than trying to kill them after infection. This anti-adherence/anti-invasion effect could prevent infection establishment.

The Bigger Picture

Antimicrobial strategies that prevent infection establishment (anti-virulence) rather than killing bacteria (bactericidal) are less likely to drive resistance development.

What This Study Doesn't Tell Us

In-vitro cell infection model. The concentrations achievable at intestinal surfaces are uncertain. Single pathogen tested.

Questions This Raises

  • ?Would lactoferricin prevent intestinal Yersinia infection in vivo?
  • ?Does this anti-virulence mechanism extend to other enteric pathogens?
  • ?Could lactoferrin supplementation prevent foodborne Yersinia infection?

Trust & Context

Key Stat:
Blocks invasion At doses too low to kill bacteria, lactoferricin still prevented them from sticking to and invading cells — anti-virulence protection complementing killing
Evidence Grade:
Preliminary in-vitro evidence with clear dose-dependent anti-adhesion and anti-invasion data in a standard cell infection model.
Study Age:
Published in 2004. Anti-virulence approaches to infection prevention have grown in importance as antibiotic resistance increases.
Original Title:
Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells.
Published In:
Journal of medical microbiology, 53(Pt 5), 407-412 (2004)
Database ID:
RPEP-00902

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can lactoferricin prevent infection without killing bacteria?

Yes — this study shows it blocks bacteria from attaching to and invading cells even at low doses. It's like coating cells with a non-stick surface that bacteria can't grab onto.

Is this better than just killing bacteria?

It's complementary. Killing bacteria can drive resistance, but preventing them from invading cells is harder for bacteria to evolve around. Lactoferricin does both — kill AND block invasion.

Read More on RethinkPeptides

Cite This Study

RPEP-00902·https://rethinkpeptides.com/research/RPEP-00902

APA

Di Biase, Assunta Maria; Tinari, Antonella; Pietrantoni, Agostina; Antonini, Giovanni; Valenti, Piera; Conte, Maria Pia; Superti, Fabiana. (2004). Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells.. Journal of medical microbiology, 53(Pt 5), 407-412. https://doi.org/10.1099/jmm.0.05410-0

MLA

Di Biase, Assunta Maria, et al. "Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells.." Journal of medical microbiology, 2004. https://doi.org/10.1099/jmm.0.05410-0

RethinkPeptides

RethinkPeptides Research Database. "Effect of bovine lactoferricin on enteropathogenic Yersinia ..." RPEP-00902. Retrieved from https://rethinkpeptides.com/research/di-2004-effect-of-bovine-lactoferricin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.